| Sars CoV-2 Antigen (8000101399) | |
|---|---|
| Test Mnemonic: | Sars CoV-2 Antigen |
| Specimen Requirements: | |
| Collection: |
Nasopharyngeal and anterior nasal swab.
|
| Container: |
Nasopharyngeal and anterior nasal swab specimens stored in:
• CDC viral transport media
• Hardy R99 viral transport media
• COPAN* UTM® Universal transport media
• Bartels FlexTrans™ transport media [Trinity Biotech]
• WHO viral transport media
• Saline (Phosphate Buffered Saline (PBS) or 0.9% NaCI)
• YOCON Viral Transport Media
|
| Minimum Volume: | 400 uL of viral sample. |
| Storage/Transport: |
|
| Specimen Preparation: | None |
| Stability: | Room Temperature up to 30°C- 24 hours. Refrigerated 2-8°C- 48 hours. |
| Causes for Rejection: | Inappropriate source. Prolonged storage at room temperature. Specimens received in wrong containers. Wooden swabs. Specimen container unlabeled or labeled incorrectly. No date and time of collection. |
| Reference Range: | Not Detected. |
| Turnaround Time: | Two business days. |
| Methodology: | Chemiluminescent immunoassay |
| Performed: | |
| Lab: | Clinical Chemistry |
| Clinical Indication: | A chemiluminescent immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens. |
| Patient Preparation : | None |
| CPT 4 Code: | 87426 |
| When ordering tests for which Medicare or Medicaid reimbursement will be sought, physicians should only order tests that are medically necessary for the diagnosis or treatment of the patient. Components of the organ or disease panels may be ordered individually. The diagnostic information must substantiate all tests ordered and must be in the form of an ICD-10 code or its verbal equivalent. | |